VRA Enterprises LLC, doing business as a Tampa pharmacy called Precision RX, settled allegations it fraudulently billed ...

Democrats in the House are making a push to roll back the Trump administration's new prior-authorization demonstration. | ...

People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the makers of Ozempic, Wegovy, Mounjaro and Zepbound.

ASC leaders are closely watching several legislative issues as the government shutdown continues into its third week, increasing the potential for delays in CMS’ rulemaking and other administrative ...

The Review Choice Demonstration (RCD) was a home health boogeyman when the program was announced in 2018, with industry stakeholders fearing it would cause major disruptions. Fast forward some years ...

Our Health Care Group reviews a new five-year CMS demonstration project requiring ambulatory surgical centers (ASCs) in 10 states to obtain approval before performing certain procedures. The ...

As congressional Democrats and Republicans battle over how to avert a potential government shutdown, another issue -- reining in prior authorizations -- remains on both parties' radar screens, ...

Trina Paul is a Breaking News and Personal Finance Writer at Investopedia, covering topics like retirement, consumer debt, and retail investing. She focuses on making complex financial topics ...

At RISE West, we're not just talking about AI - we're showing exactly how it solves healthcare's most expensive compliance challenge," said Chetan Parikh, CEO of RAAPID. "Attendees will see our ...

Informal caregivers often face considerable financial burdens, including the need to cover health-related costs for the loved ones they are caring for, loss of employment or reduction in pay due to ...

In July, the Centers for Medicare and Medicaid Services (CMS) announced a six-year test of more aggressive prior authorization in Medicare’s traditional fee-for-service (FFS) program. CMS will conduct ...